Literature DB >> 18234638

Expression of CXC chemokine IP-10 in patients with chronic hepatitis B.

Jian Wang1, Jin-Hong Zhao, Ping-Ping Wang, Gui-Ju Xiang.   

Abstract

BACKGROUND: Chemokines have strong chemoattractant effects and are involved in a variety of immune and inflammatory reactions, such as attracting activated T lymphocytes, neutrophils, monocytes and natural killer cells via the pathway of G protein-coupled receptors to sites of inflammatory injury and contribute to wound repair. This investigation was designed to assess the levels of chemokine interferon-gamma inducible protein-10 (IP-10) and IP-10 mRNA, and the relationship between IP-10 mRNA and HBV-DNA and alanine aminotransferase (ALT) in patients with chronic hepatitis B.
METHODS: The levels of IP-10 mRNA in peripheral blood mononuclear cells (PBMCs) were kinetically detected by real-time polymerase chain reaction (PCR). The rate of chemokine/GAPDH was regarded as the extreme level of chemokine. The level of IP-10 in serum was measured by enzyme linked immunosorbent assay (ELISA), and the expression of IP-10 in hepatic biopsy tissue was detected by streptavidin-peroxidase (SP) immunohistochemistry.
RESULTS: The level of IP-10 mRNA in the PBMCs of patients was 0.7387+/-0.0768 (lg cDNA/lg GAPDH); it was significantly higher in patients with chronic hepatitis B than that in normal controls (P<0.001). The level of IP-10 in the serum of patients was 660.9+/-75.5 pg/ml. There was a significant difference between patients with chronic hepatitis B and normal controls (P<0.05). In patients with chronic hepatitis B, the level of IP-10 mRNA in PBMCs was correlated with the IP-10 plasma level (r=0.7312, P<0.001), and the IP-10 plasma level was fairly correlated with the levels of ALT and HBV-DNA plasma (r=0.7235, P<0.001; r=0.7371, P<0.001). IP-10 was found by immunohistochemical analysis to be selectively upregulated on sinusoidal endothelium.
CONCLUSIONS: The expression of IP-10 mRNA in PBMCs, IP-10 plasma concentration and the expression of IP-10 in sinusoidal endothelium are all high in patients with chronic hepatitis B. Chemokine IP-10 may play an important role in trafficking inflammatory cells to the local focus in the liver and induce the development of the chronicity of hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234638

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  15 in total

1.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  CXC chemokine IP-10: a key actor in liver disease?

Authors:  Lin-Jiao Chen; Juan Lv; Xiao-Yu Wen; Jun-Qi Niu
Journal:  Hepatol Int       Date:  2013-07-16       Impact factor: 6.047

3.  Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes.

Authors:  Yu Zhou; Shuo Wang; Jing-Wei Ma; Zhang Lei; Hui-Fen Zhu; Ping Lei; Zhuo-Shun Yang; Biao Zhang; Xin-Xin Yao; Chuan Shi; Li-Fang Sun; Xiong-Wen Wu; Qin Ning; Guan-Xin Shen; Bo Huang
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

4.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

5.  Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians.

Authors:  Lu-Lu Gong; Bin-Bin Zhao; Wen-Feng Fan; Lu-Yu Gong; Cai-Feng Chen; Jing-Jun Liu; Xuan Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

7.  Association of mRNA expression level of IP-10 in peripheral blood mononuclear cells with HBV-associated acute-on-chronic liver failure and its prognosis.

Authors:  Xiao-Lin Wang; Xiu-Ji Chen; Hai-Hui Ye; Ling-Xiang Xing; Xiao-Ying Han; Zheng-Jiang Cheng; Shao-Jun Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

8.  Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.

Authors:  Dilek Yıldız Sevgi; Banu Bayraktar; Alper Gündüz; Banu Yılmaz Özgüven; Alper Togay; Emin Bulut; Nuray Uzun; İlyas Dökmetaş
Journal:  Wien Klin Wochenschr       Date:  2015-11-06       Impact factor: 1.704

9.  Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.

Authors:  Gregory J Dore; Vicente Soriano; Jürgen Rockstroh; Bernd Kupfer; Ellen Tedaldi; Lars Peters; Jacqueline Neuhaus; Massimo Puoti; Marina B Klein; Amanda Mocroft; Bonaventura Clotet; Jens D Lundgren
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

10.  The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant.

Authors:  Maomao Zhang; Jieqiong He; Jingbo Hou; Jian Wu; Meng Sun; Jinjin Cui; Jiangtian Tian; Miaomiao Jiang; Bo Yu
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.